Overview

Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of galantamine and CDP-choline in improving symptoms associated with schizophrenia.
Phase:
Phase 2
Details
Lead Sponsor:
Georgetown University
Collaborators:
National Institute of Mental Health (NIMH)
Washington D.C. Veterans Affairs Medical Center
Treatments:
Aripiprazole
Choline
Cytidine Diphosphate Choline
Galantamine
Olanzapine
Quetiapine Fumarate
Risperidone
Ziprasidone